Profiel
James W.
Kim worked as the Chief Executive Officer & Executive Director at SciGen Pte Ltd.
from 2016 to 2017.
He also worked as the Director of Business Development & Licensing at BIOTON SA. Dr. Kim received an undergraduate degree from Trinity International University and a doctorate degree from the University of Wisconsin.
Eerdere bekende functies van James W. Kim
| Bedrijven | Functie | Einde |
|---|---|---|
| SCIGEN LIMITED | Algemeen Directeur | 09-02-2017 |
| BIOTON S.A. | Corporate Officer/Principal | - |
Opleiding van James W. Kim
| University of Wisconsin | Doctorate Degree |
| Trinity International University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOTON S.A. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
